Pharmaceutical Drug Targets and Diseases
From Proteopedia
(Difference between revisions)
Line 1: | Line 1: | ||
[[Image: Nexium.jpg|300px|right|thumb| AstraZeneca’s Nexium]] | [[Image: Nexium.jpg|300px|right|thumb| AstraZeneca’s Nexium]] | ||
- | + | {{#tree:id=siteTree| | |
<big>The following is a list of major phamerceutical compound targets, organized by disease. </big> | <big>The following is a list of major phamerceutical compound targets, organized by disease. </big> | ||
{{TOC limit|limit=2}} | {{TOC limit|limit=2}} | ||
- | + | **Alzheimer’s Disease | |
- | [[Acetylcholinesterase]] | + | ***[[Acetylcholinesterase]] |
- | [[Amyloid Beta]] | + | ***[[Amyloid Beta]] |
- | [[Gamma-Secratase]] | + | ***[[Gamma-Secratase]] |
- | [[Glutamate receptor (GluA2)]] | + | ***[[Glutamate receptor (GluA2)]] |
- | + | **Anemia | |
- | [[Erythropoietin]] | + | ***[[Erythropoietin]] |
- | + | **Asthma and other Pulmonary Disease States | |
- | [[Beta-2-Andrenergic Receptor]] | + | ***[[Beta-2-Andrenergic Receptor]] |
- | [[Leukotriene Receptor]] | + | ***[[Leukotriene Receptor]] |
- | + | **Autoimmune Diseases | |
- | [[Tumor Necrosis Factor Receptor]] | + | ***[[Tumor Necrosis Factor Receptor]] |
- | + | **Blood Clots & Thrombic Events | |
- | [[P2Y12]] | + | ***[[P2Y12]] |
- | + | **Cancer | |
- | [[ | + | ***Growth Factors |
- | [[Epidermal Growth Factor]] | + | ****Epidermal Growth Factor |
- | [[ | + | *****[[Epidermal Growth Factor]] |
- | [[ | + | *****[[Epidermal Growth Factor Receptor]] |
- | [[ | + | ****[[Hepatocyte Growth Factor Receptor]] |
- | [[ | + | ****[[Human Epidermal Growth Factor Receptor 2]] |
- | [[Phosphatidylinositol 3-Kinase]] | + | ****Vascular Growth Factor |
- | [[ | + | *****[[Vascular Endothelial Growth Factor]] |
- | [[ | + | *****[[Vascular Endothelial Growth Factor Receptor]] |
- | [[ | + | ***Kinases |
+ | ****[[Cell Division Cycle 7-Related Protein Kinase]] | ||
+ | ****Mitogen-Activated Proteins | ||
+ | *****Mitogen-Activated Protein Kinase | ||
+ | *****Mitogen-Activated Protein Kinase Kinase | ||
+ | *****Mitogen-Activated Protein Kinase Kinase Kinase | ||
+ | ******[[c-Raf]] | ||
+ | ****[[Phosphatidylinositol 3-Kinase]] | ||
+ | ****[[Tyrosine Kinase]] | ||
+ | ***[[Heat Shock Protein 90]] | ||
+ | ***[[p53]] | ||
+ | ***[[Mammalian Target of Rapamycin]] | ||
- | + | **Compromised Immune System | |
- | [[Granulocyte-macrophage colony-stimulating factor]] | + | ***[[Granulocyte-macrophage colony-stimulating factor]] |
- | + | **Diabetes & Hypoglycemia | |
- | [[Peroxisome Proliferator-Activated Receptors]] | + | ***[[Peroxisome Proliferator-Activated Receptors]] |
- | + | **Digestive Diseases | |
- | [[Proton Pump]] | + | ***[[Proton Pump]] |
- | + | **Erectile Dysfunction | |
- | [[cGMP-Specific Phosphodiesterase Type 5]] | + | ***[[cGMP-Specific Phosphodiesterase Type 5]] |
- | + | **HIV | |
- | [[Reverse Transcriptase]] | + | ***[[Reverse Transcriptase]] |
- | + | **Hypercholesterolemia (Elevated Cholesterol) | |
- | [[HMG-CoA Reductase]] | + | ***[[HMG-CoA Reductase]] |
- | + | **Hypertension & Congestive Heart Failure | |
- | [[Angiotensin-Converting Enzyme]] | + | ***[[Angiotensin-Converting Enzyme]] |
- | [[Calcium Channel]] | + | ***[[Calcium Channel]] |
- | + | **Inflammation & Rheumatoid Arthritis | |
- | [[Cyclooxygenase]] | + | ***[[Cyclooxygenase]] |
- | + | **Schizophrenia, Bipolar Depression, Insomnia, and Anxiety Disorders | |
- | [[Dopamine Receptor]] | + | ***[[Dopamine Receptor]] |
- | [[Andrenergic Receptor]] | + | ***[[Andrenergic Receptor]] |
- | [[Histamine Receptor]] | + | ***[[Histamine Receptor]] |
- | [[Opioid Receptor]] | + | ***[[Opioid Receptor]] |
+ | }} |
Revision as of 09:05, 17 September 2010
The following is a list of major phamerceutical compound targets, organized by disease.
Proteopedia Page Contributors and Editors (what is this?)
David Canner, Alexander Berchansky, Eran Hodis, Thomas J. Stout, Wayne Decatur